Search for stocks /

Power Finance Corporation: 21% ROE, 3.8% Dividend Yield & a Balance Sheet That Eats Borrowings for Breakfast


At a Glance

Power Finance Corporation (PFC) is basically the sugar daddy of the Indian power sector—handing out loans to every state electricity board and power project that shows up with a half-decent proposal. Stock price is ₹416, P/E a laughably low 6, and ROE an enviable 21%. Dividend yield? A cool 3.8%, which beats most FDs and the interest on that savings account you forgot exists. Q1 FY26 profit just came in at ₹4,501 crore, with the board also throwing in an interim dividend of ₹3.70/share. In short: solid earnings, low valuation, and a government backstop that makes investors sleep like babies.


Introduction

Let’s talk about PFC, the lender that’s basically the RBI’s favorite cousin when it comes to financing power projects. The company doesn’t sell products or fancy tech—it sells money. And guess what? That business is minting cash faster than your uncle at a Diwali card game.

The stock trades at a P/E of just 6, which is practically screaming “undervalued” while sipping chai. Investors love it for the juicy dividends, while PSU skeptics avoid it like a gym membership. But here’s the kicker: over the last 3 years, profits have compounded at 18%, and NPAs have been falling like Sensex on a bad budget day.

Is PFC the dark horse in your portfolio or just another PSU with heavy borrowing and low glamour? Stick around.


Business Model (WTF Do They Even Do?)

PFC is a Systemically Important NBFC—fancy words for “too big to fail.” Its entire business revolves around lending to power sector players, including state power utilities, private companies, and renewable energy projects.

Fund-Based Products: Term loans, lease financing, and refinancing for stressed assets.
Non-Fund Based Products: Guarantees, letters of comfort, and other banker-speak for “we got your back.”

Roasting aside, PFC is basically the lender of last resort for the power industry. If NTPC sneezes, PFC hands it a tissue and a ₹10,000 crore loan.


Financials Overview

Latest trailing 12-month revenue stands at ₹1,10,324 crore with PAT at ₹32,314 crore. FY25 EPS is ₹73.7, so annualized

Continue reading with a premium membership.
Become a member
error: Content is protected !!